REDDSTAR Shines at the ISCT 2014 Paris Conference

Professor of Medicine at NUI Galway, Tim O’Brien
May 14 2014 Posted: 10:07 IST

REDDSTAR Co-ordinator and Professor of Medicine at NUI Galway, Tim O’Brien, and Orbsen Therapeutics’ Head of Research, Dr Steve Elliman took part in an interactive workshop during the International Society for Cellular Therapy (ISCT) 20th Anniversary meeting. The workshop showcased ‘EU-funded projects on Cellular Therapies’ and was held in Paris recently.

REDDSTAR (Repair of Diabetic Damage by Stromal Cell Administration) is an EU funded project which will develop and test stromal cell therapy to treat for diabetes mellitus. The objective is to control blood glucose while also addressing a range of diabetic complications.

Steve Elliman added, “The 20th ISCT Meeting in Paris featured some outstanding updates in the translational development of cell therapies. I personally enjoyed the Plenary Session of the development of cell therapies for leukaemias and inherited immunodeficiences, which included an inspirational discussion of the challenges and successes of gene-modified cell therapies by Professor Adrian Thrasher from Great Ormond Street Hospital in the London and Professor Bruce Levine from University of Pennsylvania. In addition, there was a well-attended and detailed discussion of the development of clinical MSCs for Acute Respiratory Distress Syndrome (ARDS), which was very informative for groups entering the clinical phase of cell therapy testing.”

In response to the EU-funded projects’ workshop and REDDSTAR’s involvement, Massimo Dominici, MD, President of the International Society for Cellular Therapy 2014-16 remarked, “The presence of highly valuable speakers representing EU funded research projects represented true added value within our 20th Anniversary Meeting. The feeling I have is that cell therapy in Europe has grown incredibly and, certainly, the EU FP7 granting has provided the proper boost in translating basic concepts into clinical realities for still as yet untreatable diseases. As a global society, ISCT looks forward to showcasing again these EU-based achievements in our future events worldwide.”

The REDDSTAR-sponsored session (Workshop 5) was chaired by Dr Mark Lowdell of the Royal Free and University College Medical School, University College London, UK and Dr David Gancberg from Directorate Health, Directorate-General for Research and Innovation, European Commission. In addition to Professor O’ Brien and Dr Elliman, the workshop also featured Prof. Anne Dickinson, MD, of Newcastle University, UK, a project leader in Celleurope and Dr Pierre Layrolle, Co-ordinator of Reborne based at INSERM in Toulouse.


Marketing and Communications Office